CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Restylane Skinboosters Vital Lidocaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06372782
NCT06372782N/ACompleted

A Randomized, Split-Hand, Subject-Blinded Study Comparing Pain, Safety and Effectiveness of Restylane Skinboosters Vital Lidocaine and Restylane Vital Without Lidocaine for Improved Appearance of the Dorsal Hand in Chinese Subjects

Galderma R&D·interventional·Posted Apr 18, 2024·Updated Oct 10, 2025

In Brief

A clinical study evaluating Restylane Skinboosters Vital Lidocaine and Restylane Vital for Skin Aging of Dorsal Hands. Completed, enrolled 90 participants across 3 sites.

Detailed Summary

This is a randomized, multi-center, split-hand, subject-blinded study comparing pain, safety and effectiveness of Restylane Skinboosters Vital Lidocaine and Restylane Vital without lidocaine for improving appearance of the dorsal hands in Chinese subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedApr 18, 2024
Enrollment StartApr 24, 2024
Primary CompletionJun 28, 2024
Study CompletionJul 16, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.2 years ago

Interventions

Restylane Skinboosters Vital Lidocainedevice

Each subject will receive treatment on Day 1 with Restylane Skinboosters Vital Lidocaine in one hand and Restylane Vital in the opposite hand, as randomly assigned.

Restylane Vitaldevice

Each subject will receive treatment on Day 1 with Restylane Vital in one hand and the experimental device in the opposite hand, as randomly assigned